Evaluation of Ocular Comfort With ISTA Tears vs Systane

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• OSDI >12

Exclusion Criteria:

• Presence of any active ocular disease other than dry eye